Fund Holdings — Krensavage Asset Management, LLC

Total Portfolio Value:
$225.5K
Total Bought:
$24.4K
Total Sold:
$80.2K
Net Transaction:
-$55.8K
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Exelixis, Inc.(EXEL)1,899,0791,566,140-332,939$45.6K$37.2K16.48%-$8.4K
United Therapeutics Corporation(UTHR)200,872156,714-44,158$44.2K$36.0K15.96%-$8.2K
Biogen Inc.(BIIB)160,480134,068-26,412$41.5K$28.9K12.82%-$12.6K
Taro Pharmaceutical Indus646,453647,868+1,415$27.0K$27.4K12.16%+$422
Cardinal Health, Inc.(CAH)281,476235,656-45,820$28.4K$26.4K11.69%-$2.0K
Enanta Pharmaceuticals, Inc.(ENTA)742,8241,124,586+381,762$7.0K$19.6K8.71%+$12.6K
Jazz Pharmaceuticals plc(JAZZ)100,000101,151+1,151$12.3K$12.2K5.40%-$119
Regeneron Pharmaceuticals, Inc.(REGN)47,25612,494-34,762$41.5K$12.0K5.33%-$29.5K
BioNTech SE(BNTX)0120,000+120,000$0$11.1K4.91%+$11.1K
Sanofi(SNY)150,400150,959+559$7.5K$7.3K3.25%-$142
Alkermes plc(ALKS)918,038257,554-660,484$25.5K$7.0K3.09%-$18.5K
Mural Oncology Plc90,83388,001-2,832$538$4300.19%-$108
Masimo Corp8,0000-8,000$938$0—-$938
Page 1 of 1
Krensavage Asset Management, LLC — 13F Holdings — Q1 2024 | TickerTrail